# OnCo record shannon-westin (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/shannon-westin/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "shannon-westin" ;
  schema:name "Shannon N. Westin"@en ;
  schema:description "Houston gynaecologic oncologist who led DUO-E, the trial that added durvalumab, with or without olaparib, to first-line chemotherapy for advanced endometrial cancer."@en ;
  schema:url <https://onco.cc/people/shannon-westin/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "endometrial", "gynaecological", "trialist" ;
  schema:jobTitle "Gynaecologic oncologist, MD Anderson Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0002-1922-0156> ;
  onco:cancers <https://onco.cc/cancers/advanced-recurrent-endometrial-cancer/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/ovarian/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-duo-e-jco-2023/> ;
  schema:affiliation <https://onco.cc/institutions/md-anderson/> .
